Defluoridation by positive single-pulse current electrocoagulation from photovoltaic wastewater: Energy consumption assessment and mechanism analysis.

The presence of fluoride ions (F-) in photovoltaic (PV) wastewater significantly affects the integrity of the ecological environment. In contrast to direct current electrocoagulation (DC-EC), positive single-pulse electrocoagulation (PSPC-EC) shows a significant reduction in both the formation of passivation films on electrodes and the consumption of electrical energy. Under the experimental conditions of an Al-Al-Al-Al electrode combination, an electrode spacing of 1.0 cm, a NaCl concentration of 0.05 mol L-1, an initial pH of 5.6, an initial F- concentration of 5 mg L-1, a current density of 5 A m-2, a pulse frequency of 500 Hz, and a 40 % duty cycle, the achieved equilibrium F- removal efficiencies were 84.0 % for DC-EC and 88.0 % for PSPC-EC, respectively, accompanied by power consumption of 0.0198 kWh·mg-1 and 0.0073 kWh·mg-1. The flocs produced in the PSPC-EC process were characterized using scanning electron microscopy, X-ray diffraction, Fourier transform infrared spectroscopy, and X-ray photoelectron spectroscopy and it is revealed that the F- removal mechanisms in the PSPC-EC process include co-precipitation, hydrogen bond complexation, and ion exchange. When the actual PV wastewater was finally subjected to treatment under the optimal PSPC-EC conditions, the F- concentration in the wastewater was reduced from 4.6 mg L-1 to 1.4 mg L-1. This paper provides both a theoretical framework and a technological basis for the application of PSPC-EC in the advanced treatment of PV wastewater.

Catalytic ozonation of reverse osmosis membrane concentrates by catalytic ozonation: Properties and mechanisms.

Ni-Mn@KL ozone catalyst was prepared for the efficient treatment of reverse osmosis membrane concentrates. The working conditions and reaction mechanism of the ozone-catalyzed oxidation by Ni-Mn@KL were systematically studied. Then, a comprehensive CRITIC weighting-coupling coordination evaluation model was established. Ni-Mn@KL was characterized by scanning electron microscopy, BET, X-ray diffraction, X-ray photoelectron spectroscopy, energy-dispersive spectrometry, and X-ray fluorescence spectrometry and found to have large specific surface area and homogeneous surface dispersion of striped particles. Under the optimum working conditions with an initial pH of 7.9 (raw water), a reaction height-to-diameter ratio of 10:1, an ozone-aeration intensity of 0.3 L/min, and a catalyst filling rate of 10%, the maximum COD removal rate was 60.5%. Free-radical quenching experiments showed that OH oxidation played a dominant role in the Ni-Mn@KL-catalyzed ozone-oxidation system, and the reaction system conformed to the second-order reaction kinetics law. Ni-Mn@KL catalysts were further confirmed to have good catalytic performance and mechanical performance after repeated utilization. PRACTITIONER POINTS: Ni-Mn@KL catalyst can achieve effective treatment of RO film concentrated liquid. High COD removal rate of RO membrane concentrated liquid was obtained at low cost. Ni-Mn@KL catalyst promotes ozone decomposition to produce ·OH and O2 -· oxidized organic matter. The Ni-Mn@KL catalyst can maintain good stability after repeated use. A CRITIC weight-coupling coordination model was established to evaluate the catalytic ozonation.

KRAS as a Prognostic and Predictive Marker in Metastatic Non-Small Cell Lung Carcinoma: A Systematic Review.

Metastatic non-small cell lung cancer (NSCLC) poses a significant clinical challenge, prompting a focused investigation into the role of KRAS mutations in prognosis and treatment response. Targeted therapies offer promising avenues for intervention, motivating a comprehensive analysis of existing evidence. Conducted in June 2023, our review delved into MEDLINE (Medical Literature Analysis and Retrieval System Online), Embase, Scopus, and the Cochrane Register of Controlled Trials. Rigorous inclusion and exclusion criteria guided the selection of 12 articles, comprising two randomized controlled trials (RCTs) and 10 observational studies. Multiple investigators independently executed data extraction, evaluating prognostic factors (overall and progression-free survival) and predictive outcomes (treatment and objective response). The Newcastle-Ottawa Scale (NOS) and modified Jadad scores were used for study quality assessment of observational studies and RCTs, respectively. From an initial pool of 120 articles, the 12 selected studies, spanning 2013 to 2022, encompassed 2,845 metastatic NSCLC patients. KRAS mutations, particularly the G12C variant, emerged as a pivotal factor influencing treatment response. Notably, KRAS wild type patients displayed enhanced responses to platinum-based chemotherapy, while those with KRAS mutations exhibited favourable outcomes with immune checkpoint inhibitors (ICIs). The role of KRAS mutations as prognostic indicators in metastatic NSCLC is underscored by this systematic review, with implications for both survival and treatment response. The discernment between KRAS wild type and mutant patients offers insights into tailored therapeutic strategies, with platinum-based chemotherapy and immune checkpoint inhibitors emerging as context-dependent options. Nevertheless, more research is required to solidify the predictive role of KRAS and explore the efficacy of KRAS inhibitors and other targeted therapies, paving the way for refined and personalized interventions in the management of metastatic NSCLC.

Global epidemiology of cannabis use disorders and its trend from 1990 to 2019: Benchmarking analysis of the global burden of disease study.

Introduction: Cannabis is one of the most widely used psychoactive substances globally, with an increasing trend in its legalization for both medical and recreational purposes in various countries. While cannabis offers potential therapeutic benefits, its regular use can lead to the development of Cannabis Use Disorders (CUDs). Understanding the epidemiology of CUDs is crucial in assessing the public health burden associated with cannabis use. Methods: Epidemiological parameters of CUDs were assessed using the Global Burden of Disease (GBD) methodology across different age-groups, years, sexes, and locations worldwide from 1990-2019. Results: Globally, for both sexes combined, prevalent cases of CUDs increased steadily from 17.1 million(95%UI=12.7-22.8million) in 1990 to 23.8-million(95%UI=17.8-30.9 million) in 2019. All age-adjusted highest number of incidence observed in High-Income-North-America(HINA)(121/100,000), followed by Australasia(100/100,000), Oceania(83.97/100,000), Tropical Latin America(69.59/100,000). Globally, age-standardized disability-adjusted life years rate(ASDR) observed higher in HINA, followed by Australasia, and Western-Europe. In male, all-age incidence counts increased from 1.7 million(95%UI=1.3-2.4million) in 1990 to 2.4 million(95%UI=1.8-3.2 million) in 2019. The highest annual percentage of change in age-standardized incidence rate(ASIR) was found in East-Asia (22%) followed by Middle-East and North-Africa(MENA)(15%). The age group of 15-24 years exhibited the highest burden of CUDs. Conclusion: The widespread occurrence of CUDs on a global scale poses a substantial challenge to public health. Understanding the impact of CUDs and implementing evidence-based interventions is crucial in mitigating the associated individual, societal, and economic burdens. Continued research, collaboration, and knowledge dissemination are essential to inform policies, prevention efforts, and treatment strategies aimed at addressing CUDs on a global-scale.

Performance Improvement Program Review of Institutional Massive Transfusion Protocol Adherence: An Opportunity for Improvement.

BACKGROUND: Given the acuity of patients who receive MTPs and the resources they require, MTPs are a compelling target for performance improvement. This study evaluated adherence with our MTP's plasma:red blood cell ratio (FFPR) of 1:2 and platelet:red blood cell ratio (PLTR) of 1:12, to test the hypothesis that ratio adherence is associated with lower inpatient mortality. MATERIALS AND METHODS: The registry of an urban level I trauma center was queried for adult patients who received at least 6 units of packed red blood cells within 4 hours of presentation. Patients were excluded for interfacility transfer, cardiac arrest during the prehospital phase or within one hour of arrival, or for head AIS ≥5. Univariate analysis and multiple logistic regressions were performed to identify variables associated with early transfusion protocol noncompliance and the effect on inpatient mortality. RESULTS: Three hundred and eighty-three patients were included, with mean ISS of 25.9 ± 13.3 and inpatient mortality of 28.5%. Increasing age, ISS, INR, and total units of blood product transfused were associated with increased odds of mortality, while an increase in revised trauma score was associated with a decreased odds ratio of mortality. Achieving our goal ratios were protective against mortality, with OR of .451 (P = .013) and .402 (P=.003), respectively. DISCUSSION: Large proportions of critically injured patients were transfused fewer units of plasma and platelets than our MTP dictated; failure to achieve intended ratios at 4 hours was strongly associated with inpatient mortality. MTP processes and outcomes should be critically assessed on a regular basis as part of a mature performance improvement program to ensure protocol adherence and optimal patient outcome.

Preparation of composite coagulant for the removal of microplastics in water.

In this work, a composite flocculant (polyferric titanium sulfate-polydimethyldiallylammonium chloride [PFTS-PDMDAAC]) with a rich spatial network structure was prepared for the treatment of simulated wastewater containing polystyrene (PS) micro-nanoparticles. Characterization results showed that the surface of the PFTS-PDMDAAC was a three-dimensional network polymer of chain molecules that exhibited good thermal stability and formed an amorphous polymer containing multiply hydroxyl-bridged titanium and iron. When n(OH- ) : n(Fe) = 1:2, n(PO4 3- ) : n(Fe) = 0.35, n(Ti) : n(Fe) = 1:8, n(DMDAAC) : n(Fe) = 5:100, and the polymerization temperature is 60°C, the prepared composite flocculant has the best effect. The effects of dosage, pH, and agitation intensity on the flocculation properties of PFTS-PDMDAAC were also studied. The optimal removal rates of PS-µm and haze by PFTS-PDMDAAC were 85.60% and 90.10%, respectively, at a stirring intensity of 200 rpm, a pH of 9.0, and a PFTS-PDMDAAC dosage of 20 mg/L. The flocs produced by the PFTS-PDMDAAC flocculation were large and compact in structure, and the flocculation mechanism was mainly based on adsorption bridging. Kaolin played a promoting role in the process of PS-µm removal by PFTS-PDMDAAC floc and accelerated the formation of large and dense flocs. This study provided a reference for the coagulation method to remove micro-nanopollutants in the actual water treatment process. PRACTITIONER POINTS: A composite flocculant with rich spatial network structure (PFTS-PDMDAAC) was prepared. PFTS-PDMDAAC can effectively remove micro-nano polystyrene (PS) in wastewater. The floc produced by PFTS-PDMDAAC is large and compact in structure. The flocculation mechanism of PFTS-PDMDAAC is mainly adsorption bridging.